Paul V. Lehmann, M.D., Ph.D., Professor

CEO, President and Founder

Personal Statement

My entire research career revolved around immune monitoring. Initially I pursued this field entirely in the academic setting. In 1998 I founded a company around immune monitoring, CTL. At CTL we have been continuously refining methods, reagents and instrumentation for improving the ability to reliably detect rare antigen-specific T and B cells in freshly isolated cell material, such as human blood. Not only have we been offering new developments to the scientific community, but we also have been the first ones to apply them in research, continuing to further the field. I personally have been trying to combine my new role as the head of a company that employs over 200 in the meantime, with directing research in our R&D department, and continued academic productivity in this field.

Education and Training
  • M.D., University of Tübingen, Germany
  • Ph.D., University of Tübingen, Germany
  • 1st Postdoc, Sandoz, Basel, CH, with Z. Nagy and L. Adorini
  • 2nd Postdoc, UCLA, Los Angeles, with Eli Sercarz
  • Assistant, Associate, and Full Professor with Tenure at Case Western, Cleveland
  • CEO of CTL
Peer-reviewed Publications (Google Scholar: h-index 55, 308 publications, 15,363 citations):
See full CV